Because genomic mutations are linked to tumor oncogenesis and progression, we observed 10,953 patients from 32 TCGA studies in total (https://www.cbioportal.org), and found that 804 (7%) of them carried at least one PRKDC gene mutation. Here, PRKDC is linked to neoplasm.